Table 3.
Tumor attributes by PASH Status among those developing cancer
| NO (N=789) |
YES (N=34) |
p value | |
|---|---|---|---|
| Breast Cancer Type | 0.292 | ||
| Invasive | 581 (81.7) | 23 (74.2) | |
| In situ | 130 (18.3) | 8 (25.8) | |
| Tumor Type, Invasive Cancers | 0.521 | ||
| Ductal | 301 (61.2) | 16 (76.2) | |
| Lobular | 59 (12) | 2 (9.5) | |
| Mixed Ductal and Lobular | 64 (13) | 2 (9.5) | |
| Other | 68 (13.8) | 1 (4.8) | |
| Time to Breast Cancer | 0.436 | ||
| <5 Years | 159 (20.2) | 5 (14.7) | |
| 5+ Years | 630 (79.8) | 29 (85.3) | |
| Laterality of Cancer | 0.003 | ||
| Ipsilateral | 372 (53.2) | 25 (80.6) | |
| Contralateral | 327 (46.8) | 6 (19.4) | |
| Laterality of Cancer (Cancer <5 Years after Biopsy) | 0.833 | ||
| Ipsilateral | 93 (64.6) | 3 (60.0) | |
| Contralateral | 51 (35.4) | 2 (40.0) | |
| Laterality of Cancer (Cancer 5+ Years after Biopsy) | |||
| Ipsilateral | 279 (50.3) | 22 (84.6) | 0.001 |
| Contralateral | 276 (49.7) | 4 (15.4) |
Values displayed as number (percent). P-values based on chi-square test of significance. Numbers may not always sum to column totals due to missing values for some subjects.